|
2Z62
Crystal structure of the TV3 hybrid of human TLR4 and hagfish VLRB.61
Deposited 2007-07-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
27–228(202 aa)
Fragment:TLR4, UNP residues 27-228(human), VLRB.61, UNP residues 128-199(Inshore hagfish)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.5;296 K;0.2M NaCl, 0.1M Bis-Tris Propane, 33% PEG 1000, pH 5.50, VAPOR DIFFUSION, temperature 296K
|
Resolution 1.70 Å
R-free 0.208
|
|
2Z63
Crystal structure of the TV8 hybrid of human TLR4 and hagfish VLRB.61
Deposited 2007-07-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
27–527(501 aa)
Fragment:TLR4, UNP residues 27-527(human), VLRB.61, UNP residues 133-199(Inshore hagfish)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;277 K;0.2M Sodium Citrate, 0.1M Bis-Tris Propane, 27% PEG 1000, pH 6.50, VAPOR DIFFUSION, temperature 277K
|
Resolution 2.00 Å
R-free 0.298
|
|
2Z65
Crystal structure of the human TLR4 TV3 hybrid-MD-2-Eritoran complex
Deposited 2007-07-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
27–228(202 aa)
Fragment:TV3, UNP residues 27-228(human), E5564, UNP residues 19-158(Inshore hagfish)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 4.5;296 K;0.2M Ammonium Sulfate, 0.1M Sodium Acetate, 20% PEG 4000, 5% Ethanol, pH 4.5, VAPOR DIFFUSION, temperature 296K
|
Resolution 2.70 Å
R-free 0.289
|
|
2Z65
Crystal structure of the human TLR4 TV3 hybrid-MD-2-Eritoran complex
Deposited 2007-07-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
27–228(202 aa)
Fragment:TV3, UNP residues 27-228(human), E5564, UNP residues 19-158(Inshore hagfish)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 4.5;296 K;0.2M Ammonium Sulfate, 0.1M Sodium Acetate, 20% PEG 4000, 5% Ethanol, pH 4.5, VAPOR DIFFUSION, temperature 296K
|
Resolution 2.70 Å
R-free 0.289
|
|
2Z66
Crystal structure of the VT3 hybrid of human TLR4 and hagfish VLRB.61
Deposited 2007-07-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
383–627(245 aa)
Fragment:VLRB.61, UNP residues 24-82(Inshore hagfish), TLR4, UNP residues 383-228(human)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.5;277 K;0.2M Lithium Sulfate, 0.1M Sodium Acetate, 24% PEG 4000, pH 5.50, temperature 277K, VAPOR DIFFUSION
|
Resolution 1.90 Å
R-free 0.219
|
|
2Z66
Crystal structure of the VT3 hybrid of human TLR4 and hagfish VLRB.61
Deposited 2007-07-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
383–627(245 aa)
Fragment:VLRB.61, UNP residues 24-82(Inshore hagfish), TLR4, UNP residues 383-228(human)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.5;277 K;0.2M Lithium Sulfate, 0.1M Sodium Acetate, 24% PEG 4000, pH 5.50, temperature 277K, VAPOR DIFFUSION
|
Resolution 1.90 Å
R-free 0.219
|
|
2Z66
Crystal structure of the VT3 hybrid of human TLR4 and hagfish VLRB.61
Deposited 2007-07-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
383–627(245 aa)
Fragment:VLRB.61, UNP residues 24-82(Inshore hagfish), TLR4, UNP residues 383-228(human)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.5;277 K;0.2M Lithium Sulfate, 0.1M Sodium Acetate, 24% PEG 4000, pH 5.50, temperature 277K, VAPOR DIFFUSION
|
Resolution 1.90 Å
R-free 0.219
|
|
2Z66
Crystal structure of the VT3 hybrid of human TLR4 and hagfish VLRB.61
Deposited 2007-07-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
383–627(245 aa)
Fragment:VLRB.61, UNP residues 24-82(Inshore hagfish), TLR4, UNP residues 383-228(human)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.5;277 K;0.2M Lithium Sulfate, 0.1M Sodium Acetate, 24% PEG 4000, pH 5.50, temperature 277K, VAPOR DIFFUSION
|
Resolution 1.90 Å
R-free 0.219
|
|
3FXI
Crystal structure of the human TLR4-human MD-2-E.coli LPS Ra complex
Deposited 2009-01-21
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
27–631(605 aa)
Fragment:extracellular domain, residues 27-631
Chain B
27–631(605 aa)
Fragment:extracellular domain, residues 27-631
|
Not recorded
|
FTT 3-HYDROXY-TETRADECANOIC ACID × 8
DAO LAURIC ACID × 2
MYR MYRISTIC ACID × 2
PO4 PHOSPHATE ION × 8
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;278 K;50mM MgCl2, 0.1M Na-HEPES pH 7.5, 30% PEG MME 550, VAPOR DIFFUSION, HANGING DROP, temperature 278K
|
Resolution 3.10 Å
R-free 0.281
|
|
3UL7
Crystal structure of the TV3 mutant F63W
Deposited 2011-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
28–228(201 aa)
Fragment:UNP RESIDUES 28-228, UNP RESIDUES 126-199
|
Mutation:F63W
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
FUL beta-L-fucopyranose × 1
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.5;296 K;0.1M Bis-Tris (pH5.5), 36% PEG 1000, 0.2M Lithium sulfate, VAPOR DIFFUSION, temperature 296K
|
Resolution 2.37 Å
R-free 0.271
|
|
3UL8
Crystal structure of the TV3 mutant V134L
Deposited 2011-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
27–228(202 aa)
Fragment:UNP RESIDUES 27-228, UNP RESIDUES 126-199
|
Mutation:V134L
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
FUL beta-L-fucopyranose × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.5;296 K;0.1M Bis-Tris(pH5.5), 36% PEG 1000, 0.2M Lithium sulfate, VAPOR DIFFUSION, temperature 296K
|
Resolution 2.50 Å
R-free 0.300
|
|
3UL9
structure of the TV3 mutant M41E
Deposited 2011-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
28–228(201 aa)
Fragment:UNP RESIDUES 28-228, UNP RESIDUES 126-199
|
Mutation:M41E
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
FUL beta-L-fucopyranose × 1
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.5;296 K;0.1M Bis-Tris(pH5.5), 36% PEG 1000, 0.2M Lithium sulfate, VAPOR DIFFUSION, temperature 296K
|
Resolution 2.45 Å
R-free 0.306
|
|
3ULA
Crystal structure of the TV3 mutant F63W-MD-2-Eritoran complex
Deposited 2011-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
27–228(202 aa)
Fragment:UNP RESIDUES 27-228, UNP RESIDUES 126-199
|
Mutation:F63W
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
E55 3-O-DECYL-2-DEOXY-6-O-{2-DEOXY-3-O-[(3R)-3-METHOXYDECYL]-6-O-METHYL-2-[(11Z)-OCTADEC-11-ENOYLAMINO]-4-O-PHOSPHONO-BETA-D-GLUCOPYRANOSYL}-2-[(3-OXOTETRADECANOYL)AMINO]-1-O-PHOSPHONO-ALPHA-D-GLUCOPYRANOSE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 4.5;296 K;0.1M sodium acetate (pH4.5), 22% w/v PEG 8000, 0.2M lithium sulfate, VAPOR DIFFUSION, temperature 296K
|
Resolution 3.60 Å
R-free 0.341
|
|
3ULA
Crystal structure of the TV3 mutant F63W-MD-2-Eritoran complex
Deposited 2011-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
27–228(202 aa)
Fragment:UNP RESIDUES 27-228, UNP RESIDUES 126-199
|
Mutation:F63W
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
E55 3-O-DECYL-2-DEOXY-6-O-{2-DEOXY-3-O-[(3R)-3-METHOXYDECYL]-6-O-METHYL-2-[(11Z)-OCTADEC-11-ENOYLAMINO]-4-O-PHOSPHONO-BETA-D-GLUCOPYRANOSYL}-2-[(3-OXOTETRADECANOYL)AMINO]-1-O-PHOSPHONO-ALPHA-D-GLUCOPYRANOSE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 4.5;296 K;0.1M sodium acetate (pH4.5), 22% w/v PEG 8000, 0.2M lithium sulfate, VAPOR DIFFUSION, temperature 296K
|
Resolution 3.60 Å
R-free 0.341
|
|
4G8A
Crystal structure of human TLR4 polymorphic variant D299G and T399I in complex with MD-2 and LPS
Deposited 2012-07-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
23–629(607 aa)
Fragment:UNP RESIDUES 23-629
Chain B
23–629(607 aa)
Fragment:UNP RESIDUES 23-629
|
Mutation:D299G, T399I
Mutation:D299G, T399I
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
LP4 2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-4-O-phosphono-beta-D-glucopyranose × 2
LP5 (R)-((2R,3S,4R,5R,6R)-3-HYDROXY-2-(HYDROXYMETHYL)-5-((R)-3-HYDROXYTETRADECANAMIDO)-6-(PHOSPHONOOXY)TETRAHYDRO-2H-PYRAN-4-YL) 3-HYDROXYTETRADECANOATE × 2
DAO LAURIC ACID × 2
MYR MYRISTIC ACID × 2
KDO 3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;26-30% (w/v) PEG1000, 0.1M Tris-HCl (pH 8.0), VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.40 Å
R-free 0.249
|
|
5NAM
NMR structure of TLR4 transmembrane domain (624-670) in DMPG/DHPC bicelles
Deposited 2017-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
623–670(48 aa)
Fragment:UNP residues 623-670
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;313 K;Ionic strength (raw mmCIF value) 10;Pressure AMBIENT
NMR sample composition
0.5 mM [U-13C; U-15N] TLR4-TM, 71 mM DHPC, 29 mM DMPG, 10 mM imidazole, 0.01 % sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM [U-13C; U-15N] TLR4-TM, 71 mM DHPC, 29 mM DMPC, 10 mM imidazole, 0.01 % sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM [U-13C; U-15N] TLR4-TM, 50 mM [U-2H] DPC, 10 mM imidazole, 0.01 % sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
5NAO
NMR structure of TLR4 transmembrane domain (624-657) in DPC micelles
Deposited 2017-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
623–657(35 aa)
Fragment:UNP residues 623-657
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;313 K;Ionic strength (raw mmCIF value) 20;Pressure AMBIENT
NMR sample composition
1.0 mM [U-100% 13C; U-100% 15N] TLR4-TM, 100 mM [U-99% 2H] DPC, 20 mM sodium phosphate, 0.01 % sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
8WO1
Cryo-EM Structure of Human TLR4/MD-2/DLAM5 Complex
Deposited 2023-10-06
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
27–631(605 aa)
Chain B
27–631(605 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
GP4 2-amino-2-deoxy-4-O-phosphono-alpha-D-glucopyranose × 2
2IL (3R)-3-(dodecanoyloxy)tetradecanoic acid × 2
0IL (3R)-3-(tetradecanoyloxy)tetradecanoic acid × 2
X6N [(2~{R},3~{S},4~{R},5~{S})-2-(hydroxymethyl)-5-methoxy-4,6-bis(oxidanyl)oxan-3-yl] dihydrogen phosphate × 2
A1L01 (3~{S})-3-decanoyloxytetradecanoic acid × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.24 Å
|
|
8WTA
Cryo-EM Structure of Human TLR4/MD-2/DLAM3 Complex
Deposited 2023-10-18
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
27–631(605 aa)
Chain B
27–631(605 aa)
|
Not recorded
|
GP4 2-amino-2-deoxy-4-O-phosphono-alpha-D-glucopyranose × 2
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
2IL (3R)-3-(dodecanoyloxy)tetradecanoic acid × 4
0IL (3R)-3-(tetradecanoyloxy)tetradecanoic acid × 2
XIQ 2-(hydroxymethyl)-5-methoxy-3,6-bis(oxidanyl)pyran-4-one × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|